PubMed Health⌕ Search

PubMed · 3610896

Multiple treatment interference in the alternating treatments design as a function of the intercomponent interval length.

Abstract

In experimental designs requiring the administration of more than one treatment to the same subject(s), the effect of one treatment may be influenced by the effect of another treatment (Campbell & Stanley, 1963), a phenomenon known as multiple treatment interference. We conducted two studies in which multiple treatment interference in an alternating treatments design was shown to be a function of the length of the intercomponent interval (ICI) separating treatment conditions. In the first study, we evaluated the effects of four different treatments on the mouthing of a severely retarded boy. Under a 1-min ICI no consistent differential responding to treatment was obtained. Differential responding emerged when the ICI was increased from 1 min to 120 min, thus suggesting multiple treatment interference in the lack of differential responding under a 1-min changeover interval. Functional control of the nondifferential and differential responding as a function of the ICI length was replicated in a reversal phase. In the second study, we compared two treatment procedures for the disruptive noncompliant behavior of a moderately retarded boy. Multiple treatment interference (i.e., the lack of differential responding) occurred with the 1-min intercomponent interval. An increase to a 120-min ICI again resulted in differential responding. A replication of multiple treatment interference by a reversal to a short interval phase was not achieved in the second subject. Results of this study support much of the basic literature on discrimination and multiple treatment interference.(ABSTRACT TRUNCATED AT 250 WORDS)

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

J J McGonigle, J Rojahn, J Dixon, P S Strain. 1987. Multiple treatment interference in the alternating treatments design as a function of the intercomponent interval length.. https://doi.org/10.1901/jaba.1987.20-171

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

Functional regression analysis using an F test for longitudinal data with large numbers of repeated measures.

Longitudinal data sets from certain fields of biomedical research often consist of several variables repeatedly measured on each subject yielding a large number of observations. This characteristic complicates the use of traditional longitudinal modelling strategies, which were primarily developed for studies with a relatively small number of repeated measures per subject. An innovative way to model such 'wide' data is to apply functional regression analysis, an emerging statistical approach in which observations of the same subject are viewed as a sample from a functional space. Shen and Faraway introduced an F test for linear models with functional responses. This paper illustrates how to apply this F test and functional regression analysis to the setting of longitudinal data. A smoking cessation study for methadone-maintained tobacco smokers is analysed for demonstration. In estimating the treatment effects, the functional regression analysis provides meaningful clinical interpretations, and the functional F test provides consistent results supported by a mixed-effects linear regression model. A simulation study is also conducted under the condition of the smoking data to investigate the statistical power for the F test, Wilks' likelihood ratio test, and the linear mixed-effects model using AIC.

Behavior Therapy↗

[Improvement of medical care by supporting the intention to change health risk behavior].

A large proportion of disease and death cases could be prevented, if efficacious programs, particularly concerning tobacco smoking, obesity, and alcohol risk drinking, could be applied. Feasible approaches are based, among others, on the Transtheoretical Model of intentional health behavior change. This model allows to develop practical approaches to reduce risk factors of common diseases at the general population level. Evidence about the promotion of the intention to change health risk behaviors revealed successes, e. g., according to smoking cessation. The effects are growing by time. Intervention that is focused at the promotion of change of health risk behaviors can add to the improvement of health care.

Behavior Therapy↗

Limitations of pharmacotherapy: behavioral approaches to chronic pain.

Pharmacotherapy is most appropriate in acute pain, whereas in chronic pain states behavioral approaches or a combination of behavioral treatment and pharmacotherapy is more appropriate. In this chapter we first describe the role of learning and memory as well as other psychological factors in the development of chronic pain and emphasize that chronic pain must viewed as the result of a learning process with resulting central neuroplastic changes. We then describe operant behavioral and cognitive-behavioral treatments as well as biofeedback and relaxation techniques and present innovative treatment procedures aimed at altering central pain memories. We complete the section with a discussion of combined behavioral and pharmacological approaches and an interdisciplinary view.

Behavior Therapy↗